Screener
Capricor Therapeutics CAPR Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| LONG-TERM LIABILITIES | |||
| Lease liabilities, net of current | 13,943,595 | 14,320,389 | |
| TOTAL LONG-TERM LIABILITIES | 13,943,595 | 14,320,389 | |
| TOTAL LIABILITIES | 47,580,884 | 50,157,149 | |
| COMMITMENTS AND CONTINGENCIES (NOTE 15) | |||
| STOCKHOLDERS’ EQUITY | |||
| Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding | — | — | |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 57,664,673 and 57,370,909 shares issued and outstanding, respectively | 57,665 | 57,371 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's total liabilities?
- Capricor Therapeutics (CAPR) reported total liabilities of $47.58M in Q1 2026.
- How has Capricor Therapeutics's total liabilities changed year-over-year?
- Capricor Therapeutics's total liabilities increased by 82.2% year-over-year, from $26.12M to $47.58M.
- What is the long-term trend for Capricor Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Capricor Therapeutics's total liabilities has grown at a 50.9% compound annual growth rate (CAGR), from $6.42M to $50.16M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Capricor Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude